VIRRX, INC

Company Information
Address VIRRX, INC
1609 ADGERS WHARF DR
CHESTERFIELD, MO, 63017


Information

DUNS: 42417787

# of Employees: N/A


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. An HBV polymerase RNA binding assay suitable for inhibitor screening

    Amount: $260,910.00

    DESCRIPTION (provided by applicant): Hepatitis B virus (HBV) is a hepatotropic DNA virus that replicates by reverse transcription. It chronically infects over 350 million people worldwide and causes 6 ...

    SBIRPhase I2009Department of Health and Human Services
  2. Syrian Hamster as a Permissive Model for Testing Anti-Adenovirus Drugs

    Amount: $222,658.00

    DESCRIPTION (provided by applicant): Human adenoviruses (Ads) are a significant problem in immunosuppressed humans, especially in children undergoing allogeneic stem cell transplants. About 20% of the ...

    STTRPhase I2007Department of Health and Human Services
  3. Animal Model for Adenovirus Oncolytic Vectors

    Amount: $182,459.00

    DESCRIPTION (provided by applicant): Adenovirus vectors have also been evaluated for their efficacy in treating cancer. As cancer is the second leading cause of death in the U.S. and current therapeut ...

    STTRPhase I2004Department of Health and Human Services
  4. Anti-Cancer Vectors that Express TRAIL

    Amount: $247,645.00

    DESCRIPTION (provided by applicant): We have developed replication-competent oncolytic adenovirus (Ad) vectors for cancer gene therapy that are designed to spread rapidly from cell to cell by virt ...

    SBIRPhase I2004Department of Health and Human Services
  5. Regulatable expression of TRAIL and viral oncolysis

    Amount: $161,875.00

    DESCRIPTION (provided by applicant): We have constructed an oncolytic adenovirus vector named "KD3" that replicates selectively in cancer cells as opposed to normal cells because of a mutation in the ...

    STTRPhase I2004Department of Health and Human Services
  6. Chaperone-based tumor therapy delivered by viral vectors

    Amount: $169,167.00

    DESCRIPTION (provided by applicant): The efficacy of molecular chaperones as adjuvants for the induction of anti-tumor immunity has been demonstrated in many laboratories over the last two decades. S ...

    STTRPhase I2003Department of Health and Human Services
  7. ADENOVIRUS REPLICATION-COMPETENT ANTI-CANCER VECTOR

    Amount: $0.00

    DESCRIPTION (provided by applicant): We have developed several tumor-specific and tissue-specific replication-competent adenoviruses (Ad) vectors for cancer gene therapy. One vector, named KD3, has a ...

    STTRPhase I2002Department of Health and Human Services
  8. ADENOVIRUS REPLICATION-COMPETENT ANTI-CANCER VECTOR

    Amount: $711,039.00

    DESCRIPTION (provided by applicant): We have developed several tumor-specific and tissue-specific replication-competent adenoviruses (Ad) vectors for cancer gene therapy. One vector, named KD3, has a ...

    STTRPhase II2002Department of Health and Human Services
  9. DEVELOPMENT OF A VIRUS VECTOR VACCINE AGAINST ANTHRAX

    Amount: $140,710.00

    DESCRIPTION (provided by applicant): The events on and following September 11, 2001 have revealed our nation's vulnerability to terrorist attacks. Although much talked about during the past decade, t ...

    SBIRPhase I2002Department of Health and Human Services
  10. ADENOVIRUS REPLICATION COMPETENT ANTICANCER VECTOR

    Amount: $100,000.00

    N/A

    STTRPhase I1999Department of Health and Human Services

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government